Novel imidazo[1,2-a]pyridine derivatives as potent ATX allosteric inhibitors: Design, synthesis and promising in vivo anti-fibrotic efficacy in mice lung model
Novel imidazo[1,2-a]pyridine derivatives as potent ATX allosteric inhibitors: Design, synthesis and promising in vivo anti-fibrotic efficacy in mice lung model
复制标题
新型咪唑并[1,2-a]吡啶衍生物作为有效的 ATX 变构抑制剂:设计、合成和在小鼠肺模型中的体内抗纤维化功效
DOI:
10.1016/j.bioorg.2021.105590
复制
发表时间:
2022
影响因子:
5.1
通讯作者:
Xin Zhai
中科院分区:
文献类型:
--
作者:
Hongrui Lei;Zhen Li;Tong Li;Huinan Wu;Jing Yang;Xinlian Yang;Yu Yang;Nan Jiang;Xin Zhai
Aiming to develop novel allosteric autotaxin (ATX) inhibitors, hybrid strategy was utilized by assembling the benzyl carbamate fragment in PF-8380 onto the imidazo[1,2-a]pyridine skeleton of GLPG-1690. The piperazine moiety in GLPG-1690 was replaced with phenyl ring to enhance the π-π interactions with adjacent residues. In the light of FS-3 based ATX enzymatic assay, further structure-guided optimizations were implemented by exploring the substituents within the carbamate aromatic moiety and examining the effect of the 2-ethyl. Eventually,13cbearing 1,3-benzodioxole and 2-hydroxyethyl piperazine group was identified as a powerful ATX inhibitor with an IC50value of 2.7 nM. Subsequently,13cwas forwarded into anin vivobleomycin-induced mice lung fibrosis model. In histopathological and immunohistochemical assays,13ccould typically alleviate the severity of fibrosis tissues and effectively reduce the deposition of fibrotic biomarker α-SMA. At a dose of 60 mg/kg,13cwas observed equivalent or even better potency than GLPG-1690 with a significant inhibition of thein vivoATX activity. Except for the fundamental H-bond and π-π interactions, an extra H-bond between the 1,3-benzodioxole (O atom) and Phe306 offered great rationale in constraining the binding conformation of13c. Finally, binding free energy calculation was conducted to assist in the efficient identification of allosteric ATX inhibitors.